Respiratory syncytial virus RSV Vaccines - Biotech, Pharma and Life Science Channel

18:09 EDT 6th July 2015 | BioPortfolio

Respiratory syncytial virus (RSV) infection, which manifests primarily as bronchiolitis and/or viral pneumonia, is the leading cause of lower respiratory tract infection in infants and young children. In the US, RSV LRT infection develops annually in 4-5 million children, and more than 125,000 children are admitted per year for RSV-related illness. RSV disease is the no.1 cause of hospitalization in babies under a year of age in the US. While a monoclonal antibody is commercially available to help prevent RSV disease in infants and children at high risk for severe lung disease from RSV, a RSV vaccine still is not on the market. A number of RSV vaccine candidates have entered clinical development and further are to follow. Also, next generation antibodies against RSV with improved features are in the development pipeline as well as new therapies based on silencing RSV RNA or inhibiting key targets of the virus.

News Articles [756 Associated News Articles listed on BioPortfolio]

Inherited Herpes Virus Increases the Risk of Angina Reports HHV-6 Foundation

SANTA BARBARA, Calif., July 6, 2015 /PRNewswire/ -- Approximately 1% of the population inherits a common herpes virus that is integrated into their chromosomes. These individuals are three times ...

Gene therapy breakthrough for cystic fibrosis

“Cystic fibrosis hope as new gene therapy improves condition,” The Daily Telegraph reports. Researchers have, for the first time, managed to successfully "smuggle" healthy copies of gene...

Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets

Pfizer Inc. announced today that the United States Food and Drug Administration (FDA) accepted for review Pfizer’s new drug application (NDA) for XELJANZ® (tofacitinib citrate)...

Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot

OXFORD, England, July 2, 2015 /PRNewswire/ -- Releases of the genetically engineered Oxitec mosquito, commonly known as 'Friendly Aedes aegypti', reduced the dengue mosquito population in an area of ...

BiondVax to Close Trading on NASDAQ on July 10, 2015

NESS ZIONA, Israel, July 2, 2015 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) today announced that it will be closing trading on the NASDAQ market on Friday, July 10, 2015...

AHF Criticizes ‘Dumb & Dumber’ Star Jim Carrey for Calling Gov. Brown a ‘Fascist’ for Signing Vaccine Bill

AHF applauds California Governor Jerry Brown for signing SB 277 (Sen. Richard Pan, MD, D-Sacramento, and Sen. Ben Allen, D-Santa Monica), a bill that will eliminate nearly all ‘...

Immunovaccine Publishes Clinical Results With DPX-Survivac in Combination With an Immune-Modulating Compound

HALIFAX, NOVA SCOTIA -- (Marketwired) -- 07/02/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy company, today announc...

National Vaccine Information Center (NVIC) Says New California Law Threatens Human and Civil Rights in America

Following the June 29, 2015 enactment by Governor Jerry Brown of a California law eliminating the legal right for parents enrolling children in school to exercise vaccine exemptio...

Discovery Labs Receives Nasdaq Notification Related to Minimum Bid Price

WARRINGTON, Pa., July 1, 2015 /PRNewswire/ -- Discovery Laboratories, Inc. (Nasdaq: DSCO) announced today that, on June 29, 2015, the Company received a letter from The Nasdaq Stock Market indica...

Stationary Oxygen Concentrators Market to Reach $2 Billion by 2021: Radiant Insights, Inc.

SAN FRANCISCO, July 1, 2015 /PRNewswire/ -- Radiant Insights announce that it has added a new study Stationary Oxygen Concentrators Market Shares, Strategy, and Forecasts, Worldwide, 2015 to 2021. Wo...

Events [1 Associated Events listed on BioPortfolio]

Allergies

SMi presents the 2nd annual conference on… Allergies 8th & 9th July 2015 www.allergies-event.com/BioPortfolio

Companies [228 Associated Companies listed on BioPortfolio]

Apria Healthcare Group Inc.

Apria is a privately held company owned by a group of investment limited partnerships managed by affiliates of Blackstone (NYSE:BX). Through its Apria Healthcare LLC operating uni...

EY Laboratories inc

Manufacturer of biochemical reagents serving the needs of biochemical research in glycobiology, immunology, and microbiology. Manufacturer of rapid, simple, and stable diagnostic test kits for visual ...

SIRION Biotech GmbH

Founded in 2005, SIRION Biotech is a global leader in developing research and commercial grade viral vector solutions for industry and academic partners who are developing gene th...

Center for Infectious Disease Research

Center for Infectious Disease Research is the largest independent, non-profit organization in the U.S. focused solely on infectious disease research. Our mission is to make transf...

ResMed

ResMed (NYSE: RMD and ASX: RMD.AX) is a leading developer, manufacturer and marketer of products for the screening, treatment and long-term management of sleep-disordered breathing (SDB) and other res...

Aduro BioTech, Inc.

Aduro BioTech is a clinical-stage immunotherapy company with a platform technology for therapeutic and prophylactic vaccines for cancer and infectious diseases. The platform of at...

Madison Vaccines Incorporated

Wisconsin-based MVI is developing two plasmid DNA vaccines to treat men with prostate cancer. MVI has licensed patented technologies that were developed in the laboratory of Dr. D...

Zambon S.p.A.

Zambon is a leading Italian pharmaceutical and fine-chemical multinational company that has earned a strong reputation over the years for high quality products and services. Zambo...

RxC International

RxC International is a life sciences management consulting firm specializing in corporate strategy, new product development, and commercialization. RxC International brings strate...

Synexus

Synexus® is the world’s largest multi-national company dedicated to the recruitment and running of clinical trials at its own research centres across the globe on behalf o...

Clinical Trials [2747 Associated Clinical Trials listed on BioPortfolio]

Prevention of Severe Acute Respiratory Failure in Patients With PROOFCheck

Severe acute respiratory failure (ARF) requiring prolonged mechanical ventilation is the most common form of acute organ dysfunction in the hospital, and is often associated with multiple ...

Prospective Study for Transplant Optimization Using Functional Imaging (TROFI)

The objective of this study is to detect BOS in an early stage by using the outcome parameters generated by Functional Respiratory Imaging (FRI). Robust and automated segmentation algorith...

A Study to Investigate the Safety and Efficacy of Nivolumab in Virus-associated Tumors (CheckMate358)

The purpose of this study to investigate the safety and efficacy of using nivolumab to treat subjects who have virus-associated tumors. Certain viruses that infect human cells have been kn...

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease

This study evaluates the efficacy and safety of ombitasvir/paritaprevir/ritonavir with or without dasabuvir in adult genotype 1a or genotype 4 hepatitis C infected participants with severe...

Evaluation of Free Air Portable Air Powered Respirator

This study will compare the efficacy of the Free Air Portable Air Powered Respirator (PAPR) system versus a N95 mask in preventing nasal detection of influenza following an exposure. The i...

Safety and Efficacy of Ledipasvir/Sofosbuvir Fixed Dose Combination, With or Without Ribavirin, in Egyptian Adults With Chronic Genotype 4 HCV Infection

This study will evaluate the efficacy, safety, and tolerability of ledipasvir/sofosbuvir (LDV/SOF) fixed dose combination (FDC) with or without ribavirin (RBV) in Egyptian adults with chro...

Effects of ODM-109 on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis

In the double-blind, cross-over part of the study, ODM-109 capsules and placebo capsules for ODM-109 will be administered for 2 weeks separated by a 19-23 days wash-out period. During each...

Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection

A combined Phase Ib and IIa randomized, placebo-controlled, double-blind study of VM-1500 in healthy subjects and in patients with HIV-1 infection that are antiretroviral therapy naïve.

A Study to Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Adults

The purpose of this study is to assess the safety and immunogenicity of the investigational ChAd3-EBO-Z vaccine administered to approximately 3 000 adults in Africa as a single IM dose Con...

Outcome of New Direct Acting Agents For Hepatitis C A Community Based Experience

Chronic Hepatitis C virus (HCV) infection is the leading cause of advanced liver disease worldwide. The virus successfully evades host immune detection and has highly restricted requireme...

PubMed Articles [7587 Associated PubMed Articles listed on BioPortfolio]

The stability analysis of an SVEIR model with continuous age-structure in the exposed and infectious classes.

In this paper, an Susceptible-Vaccines-Exposed-Infectious-Recovered model with continuous age-structure in the exposed and infectious classes is investigated. These two ages are assumed to have arbitr...

Partial and total C-6 oxidation of gelling carrageenans. Modulation of the antiviral activity with the anionic character.

The optimal conditions for the full C-6 oxidation of κ- and ι-carrageenans using (2,2,6,6-tetramethylpiperidinyl)oxy (TEMPO) in the presence of sodium hypochlorite and sodium bromide were assessed. ...

Immunochromatographic assay for quantitative and sensitive detection of hepatitis B virus surface antigen using highly luminescent quantum dot-beads.

Hepatitis B virus infection is one of the major causes of hepatitis, liver cirrhosis and liver cancer. In this study, we used highly luminescent quantum dot-beads (QBs) as signal amplification probes ...

Positive strand RNA virus replication: It depends on the ends.

Global stability of an age-structured virus dynamics model with Beddington-DeAngelis infection function.

In this paper, we study an age-structured virus dynamics model with Beddington-DeAngelis infection function. An explicit formula for the basic reproductive number R0 of the model is obtained. We inves...

Quantitative impact of immunomodulation versus oncolysis with cytokine-expressing virus therapeutics.

The past century's description of oncolytic virotherapy as a cancer treatment involving specially-engineered viruses that exploit immune deficiencies to selectively lyse cancer cells is no longer adeq...

Middle East respiratory syndrome coronavirus in healthcare settings.

Attracting global attention, Middle East respiratory syndrome coronavirus (MERS-CoV) continues to cause sporadic cases and a potential risk of healthcare-associated infections. In this review, we high...

Bayesian network meta-analysis to evaluate interferon-free treatments in naive patients with genotype 1 hepatitis C virus infection.

Impact of immunosuppressive therapy on hepatitis B vaccination in inflammatory bowel diseases.

The vaccination rate against hepatitis B virus (HBV) is low in inflammatory bowel disease (IBD) patients. The Consensus from the European Crohn's and Colitis Organisation on opportunistic infections r...

Cardiovascular and respiratory mortality attributed to ground-level ozone in Ahvaz, Iran.

Ahvaz, the capital city of Khuzestan Province, which produces Iran's most oil, is on the rolls of fame in view of air pollution. It has also suffered from dust storm during the recent two decades. So,...

Videos

None available.

Medical and Biotech [MESH] Definitions

Vaccines or candidate vaccines used to prevent infection with RESPIRATORY SYNCYTIAL VIRUSES.

Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.

A species of PNEUMOVIRUS causing an important respiratory infection in cattle. Symptoms include fever, conjunctivitis, and respiratory distress.

An acute inflammatory disease of the upper RESPIRATORY TRACT, caused by paramyxoviruses, occurring primarily in infants and young children; the viruses most commonly implicated are PARAINFLUENZA VIRUS TYPE 3; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; and METAPNEUMOVIRUS.

The type species of PNEUMOVIRUS and an important cause of lower respiratory disease in infants and young children. It frequently presents with bronchitis and bronchopneumonia and is further characterized by fever, cough, dyspnea, wheezing, and pallor.


Advertisement
 

Relevant Topics

Respiratory
Latest News Clinical Trials Research Drugs Reports Corporate
Asthma COPD Cystic Fibrosis Pneumonia Pulmonary Medicine Respiratory Respiratory tract infections (RTIs) are any infection of the sinuses, throat, airways or lungs.  They're usually caused by viruses, but they can also ...

Infectious-diseases
Latest News Clinical Trials Research Drugs Reports Corporate
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...

Pneumonia
Latest News Clinical Trials Research Drugs Reports Corporate
Pneumonia (bronchopneumonia, lobar pneumonia and double pneumonia) is inflammation (swelling) of the tissue in one or both of your lungs. It is usually caused by an pneumococcal infection caused by bacteria called Streptococcus pneumoniae.  However,...

Advertisement
 
review and buy Respiratory syncytial virus RSV Vaccines market research data and corporate reports here

Channels Quicklinks